NantKwest, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
Nantkwest - Stock Of The Day
Article By: Jim Van Meerten
Thursday, February 18, 2021 5:39 PM EDT
Revenue expected to grow 132.50% next year. Earnings estimated to decrease at a compounded annual rate of 1.70% for the next 5 years.
In this article: NK
Read
NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars
Article By: Benzinga
Thursday, January 14, 2021 9:19 AM EDT
Clinical-stage immunotherapy company Nantkwest Inc NK reports positive interim data on survival rates in the Metastatic Pancreatic Cancer QUILT 88 trial on Wednesday.
In this article: NK Also: BMY, PFE
Read
Stock Charts To Watch - Monday, Feb. 3
Video By: Harry Boxer
Monday, February 3, 2020 11:00 PM EDT
Ballard Power Systems Inc. after a big move in Dec, came down hard, bounced, and then pulled back.
In this video: PCG, BLDP, CCXI, NK, AXSM, XPEL
Watch
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
Article By: The Life Sciences Report
Wednesday, January 27, 2016 6:16 PM EDT
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these companies have a good producing value for investors.
In this article: AZN, NVO, SGYP, SNY, CRMD, ORMP, CMXHY, SRNE, ALNY, ARRY, INCY, IRWD, PTIE, REGN, VRTX, AGEN, GALE, GRFS, PPHM, EVOK, ADMA, AKBA, VSTM, AST, RXDX, AGTC, NK, WVE, FATE, FLKS
Read
All Posts

Latest Tweets for $NK

No tweets yet!

PARTNER HEADLINES